Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1961 6
1962 8
1963 7
1964 17
1965 7
1966 6
1967 9
1968 19
1969 10
1970 12
1971 11
1972 9
1973 12
1974 11
1975 17
1976 12
1977 15
1978 16
1979 21
1980 18
1981 19
1982 19
1983 21
1984 32
1985 33
1986 41
1987 38
1988 28
1989 42
1990 30
1991 29
1992 30
1993 37
1994 45
1995 46
1996 42
1997 53
1998 44
1999 43
2000 45
2001 40
2002 36
2003 46
2004 48
2005 56
2006 56
2007 72
2008 70
2009 86
2010 105
2011 129
2012 134
2013 156
2014 159
2015 194
2016 197
2017 188
2018 174
2019 142
2020 184
2021 183
2022 169
2023 126
2024 164
2025 200
2026 99

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,737 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nakamoto y[au] (989 results)?
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Ma L, Hu X, Song L, Chen X, Ouyang M, Billot L, Li Q, Malavera A, Li X, Muñoz-Venturelli P, de Silva A, Thang NH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Abanto C, Arauz A, Shi H, Tang G, Zhu S, She X, Liu L, Sakamoto Y, You S, Han Q, Crutzen B, Cheung E, Li Y, Wang X, Chen C, Liu F, Zhao Y, Li H, Liu Y, Jiang Y, Chen L, Wu B, Liu M, Xu J, You C, Anderson CS; INTERACT3 Investigators. Ma L, et al. Among authors: sakamoto y. Lancet. 2023 Jul 1;402(10395):27-40. doi: 10.1016/S0140-6736(23)00806-1. Epub 2023 May 25. Lancet. 2023. PMID: 37245517 Free PMC article. Clinical Trial.
A long-acting anti-IL-8 antibody improves inflammation and fibrosis in endometriosis.
Nishimoto-Kakiuchi A, Sato I, Nakano K, Ohmori H, Kayukawa Y, Tanimura H, Yamamoto S, Sakamoto Y, Nakamura G, Maeda A, Asanuma K, Kato A, Sankai T, Konno R, Yamada-Okabe H. Nishimoto-Kakiuchi A, et al. Among authors: sakamoto y. Sci Transl Med. 2023 Feb 22;15(684):eabq5858. doi: 10.1126/scitranslmed.abq5858. Epub 2023 Feb 22. Sci Transl Med. 2023. PMID: 36812343
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial.
Shitara K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Sakamoto Y, Nishina T, Inaki K, Kuwahara Y, Wada N, Suto F, Arita T, Sugihara M, Tsuchihashi Z, Saito K, Kojima A, Yamaguchi K. Shitara K, et al. Among authors: sakamoto y. Nat Med. 2024 Jul;30(7):1933-1942. doi: 10.1038/s41591-024-02992-x. Epub 2024 May 14. Nat Med. 2024. PMID: 38745009 Free PMC article. Clinical Trial.
Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma.
Haga Y, Sakamoto Y, Kajiya K, Kawai H, Oka M, Motoi N, Shirasawa M, Yotsukura M, Watanabe SI, Arai M, Zenkoh J, Shiraishi K, Seki M, Kanai A, Shiraishi Y, Yatabe Y, Matsubara D, Suzuki Y, Noguchi M, Kohno T, Suzuki A. Haga Y, et al. Among authors: sakamoto y. Nat Commun. 2023 Dec 15;14(1):8375. doi: 10.1038/s41467-023-43732-y. Nat Commun. 2023. PMID: 38102134 Free PMC article.
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma.
Yoshimitsu M, Choi I, Kusumoto S, Shimokawa M, Utsunomiya A, Suehiro Y, Hidaka T, Nosaka K, Sasaki H, Rai S, Tamura S, Owatari S, Koh KR, Nakamura D, Tokunaga M, Sekine M, Sakamoto Y, Inagaki H, Ishida T, Ishitsuka K. Yoshimitsu M, et al. Among authors: sakamoto y. Blood. 2025 Sep 18;146(12):1440-1449. doi: 10.1182/blood.2024027902. Blood. 2025. PMID: 40373281 Clinical Trial.
Alcaptonuria.
Kosegawa M, Nakano Y, Sakamoto Y, Nishizawa Y. Kosegawa M, et al. Among authors: sakamoto y. Intern Med. 2026 May 15;65(10):1440-1441. doi: 10.2169/internalmedicine.6292-25. Epub 2025 Oct 2. Intern Med. 2026. PMID: 41034008 Free article. No abstract available.
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis.
Yamakawa K, Okamoto K, Seki Y, Ikezoe T, Ito T, Iba T, Gando S, Ushio N, Totoki T, Wada T, Asakura H, Ishikura H, Uchiba M, Uchiyama T, Kawasaki K, Kawano N, Kushimoto S, Koga S, Sakamoto Y, Tamura T, Nishio K, Hayakawa M, Matsumoto T, Madoiwa S, Mayumi T, Yamada S, Wada H; Committee of the Clinical Practice Guidelines for Management of Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis. Yamakawa K, et al. Among authors: sakamoto y. Int J Hematol. 2025 May;121(5):592-604. doi: 10.1007/s12185-024-03896-9. Epub 2024 Dec 16. Int J Hematol. 2025. PMID: 39676120 Review.
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.
Sakai D, Kadowaki S, Kawabata R, Hara H, Satake H, Takahashi M, Takeno A, Imai H, Minashi K, Kawakami T, Boku S, Matsuyama J, Sakamoto Y, Sawada K, Kataoka M, Kawakami H, Shimokawa T, Boku N, Satoh T. Sakai D, et al. Among authors: sakamoto y. J Clin Oncol. 2025 Jul;43(19):2196-2207. doi: 10.1200/JCO.24.01119. Epub 2025 May 23. J Clin Oncol. 2025. PMID: 40408613 Free PMC article. Clinical Trial.
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancy.
Kawano N, Ikezoe T, Seki Y, Yamakawa K, Okamoto K, Fukatsu M, Madoiwa S, Uchiyama T, Asakura H, Yamada S, Koga S, Ishikura H, Ito T, Iba T, Uchiba M, Kawasaki K, Gando S, Kushimoto S, Sakamoto Y, Tamura T, Nishio K, Hayakawa M, Matsumoto T, Mayumi T, Wada H; Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis. Kawano N, et al. Among authors: sakamoto y. Int J Hematol. 2025 May;121(5):605-621. doi: 10.1007/s12185-024-03887-w. Epub 2024 Dec 15. Int J Hematol. 2025. PMID: 39674834
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma.
Nomura M, Ohuchi M, Sakamoto Y, Kudo K, Yaku K, Soga T, Sugiura Y, Morita M, Hayashi K, Miyahara S, Sato T, Yamashita Y, Ito S, Kikuchi N, Sato I, Saito R, Yaegashi N, Fukuhara T, Yamada H, Shima H, Nakayama KI, Hirao A, Kawasaki K, Arai Y, Akamatsu S, Tanuma SI, Sato T, Nakagawa T, Tanuma N. Nomura M, et al. Among authors: sakamoto y. Nat Commun. 2023 Dec 13;14(1):8095. doi: 10.1038/s41467-023-43630-3. Nat Commun. 2023. PMID: 38092728 Free PMC article.
3,737 results